The intimation is filed for the submission of newspaper publication for the Financial Results for the Quarter and Financial year ended March 31, 2025.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India Limited has submitted copies of newspaper advertisements published on May 10, 2025 in Financial Express and Navshakti, as required under SEBI Listing Regulations. These ads contain the company's audited financial results for the quarter and full year ended March 31, 2025. For FY25, the company reported a Net Profit after tax of Rs 851.9 million, down from Rs 1,009.0 million in FY24, though Total Comprehensive Income rose to Rs 1,018.7 million from Rs 864.0 million. Basic and Diluted EPS for FY25 stood at Rs 40.87 versus Rs 34.50 in the prior year. For Q4 FY25, Net Profit after tax was Rs 146.8 million compared to Rs 1,009.0 million in Q4 FY24.
This is a routine regulatory filing confirming that audited results have been made public via newspapers. The FY25 results show a decline in net profit but an improvement in comprehensive income and EPS, which may have a neutral-to-modestly-positive sentiment depending on investor focus on these specific metrics.